How to Collaborate with R&D Teams to Build Credible Product Stories

A product story explains what a product is, which problem it solves and why it can be trusted. In science-led categories such as enzymes, probiotics and nutraceuticals, that story only works when the technical facts behind it are accurate. This guide sets out a practical operating model for marketing and R&D teams to build product stories together, from first concept to launch and beyond.

Why product stories fail without R&D

Most weak product stories fail in one of three ways. The claim is stronger than the data, so it has to be withdrawn. The language is so technical that buyers do not see the benefit. Or the story is accurate at launch but drifts as copy is reused across channels.

All three problems have the same root cause: the people who know the science and the people who write the copy work in sequence instead of together. R&D hands over a report, marketing interprets it, and nobody checks the interpretation. The fix is not more meetings. It is clear deliverables, clear ownership and one shared record of what has been agreed.

Agree a shared vocabulary first

Technical terms carry precise meanings that are easy to blur. Before writing anything, agree how your team will use words such as:

• Activity: the measured catalytic strength of an enzyme, expressed in defined units per gram under stated assay conditions.
• CFU: colony-forming units, the count of viable probiotic cells, which should be declared at the end of shelf life.
• Typical and guaranteed values: a typical value describes average results; a guaranteed value is a specification limit backed by testing.
• Stable: meaningless on its own. Always state under which conditions and for how long.

Our enzyme glossary is a useful shared reference for mixed teams. A one-page vocabulary sheet saves hours of rework later.

Shared stage-gates from concept to launch

Stage-gates are review points where a project cannot move forward until agreed deliverables are in place. Making them shared means both teams bring something to every gate.

1. Concept gate: R&D gives an honest feasibility view, including risks and alternatives. Marketing brings a need brief that says who the customer is, what problem they have and where the product will be sold.
2. Development gate: R&D shares lab and pilot results. Marketing drafts a claim list that uses only what those results can support.
3. Validation gate: R&D confirms stability, specifications and QC methods. Marketing and compliance check each claim’s wording against the evidence.
4. Launch gate: final technical documents, such as the TDS and CoA, are released alongside approved launch content.

Who owns what

Unclear ownership is how unsupported claims slip through. A simple responsibility table, agreed at the start, removes most of that risk.

The last row matters most. Formulas, suppliers and regulations change, and someone must be responsible for spotting when a change affects a claim.

Translating a lab result into a claim

Good translation keeps the meaning and changes only the language. Work in three steps and keep all three in writing.

• Lab finding: “Protease activity is tested on every batch against a defined specification.”
• Plain meaning: “Each batch performs consistently because its strength is checked before release.”
• Claim: “Activity-standardised protease, tested batch by batch.”

Then reverse the check: does the claim say anything the lab finding does not? If yes, rewrite it or ask R&D whether more data can be generated. For health-related wording, add a compliance review, as described in our guide on how clinical data supports marketing claims.

Tip: Ask R&D to write one sentence on what the data does not show. That sentence prevents more over-claiming than any style guide.

Keep the feedback loop running

Launch is not the end of collaboration. Customers ask questions, sales teams meet objections, and those questions are valuable research briefs.

A shared claim log makes the loop work. For each claim it records the approved wording, the evidence, the approver, the date and the channels where it is used. When a buyer asks, for example, whether a probiotic strain keeps its count in a warm warehouse, the question goes into the log as a data request rather than being answered from memory.

Running joint reviews that work

Shared gates only help if the reviews themselves are productive. A few habits make a large difference:

• Circulate data and draft copy before the meeting, so time is spent on decisions rather than reading.
• Review claims against the original data, not against a summary of it.
• Record each decision in the claim log with a named owner and a date.
• Invite QA or regulatory reviewers to every gate where wording is discussed, not only the final one.
• Keep a short list of open questions and assign each one before the meeting ends.

When R&D and marketing disagree, the default should be the more cautious wording until more evidence is available. That rule removes much of the friction, because nobody has to win the argument; they only have to agree what data would settle it.

Measuring whether collaboration works

Collaboration is easier to sustain when you can see its effect. Useful indicators include how many claims are changed or withdrawn after launch, how long it takes to turn new data into approved wording, and how many customer questions can be answered directly from the claim log. Track these over successive launches. Fewer late changes and faster, confident answers to buyers are good signs that the process is working.

Red flags to watch for

• Claims written before any data exists.
• Different wording for the same claim on the pack, website and sales deck.
• R&D seeing launch copy for the first time after it is printed.
• Supplier documents, such as CoAs, older than the current specification.
• No named owner for updating claims after a reformulation.

Working with Enzyme Bioscience

Enzyme Bioscience works with customers’ R&D and marketing teams from the formulation stage, supported by our in-house R&D and QC labs. Through our ENZYVIVE® custom-blend service we develop enzyme and probiotic blends to your brief and supply the technical documents your claims depend on. To start, request samples, a TDS or a CoA.